This is a sign of the times.
In the spine sector, a stark imbalance persists: the pool of spine surgeons remains largely unchanged, while the number of device companies proliferates.
Hundreds compete for limited access to U.S. hospitals and ASCs, creating an increasingly saturated market.
This overcrowding empowers cash-rich firms to acquire assets from liquidity-strapped competitors, accelerating consolidation.
A recent example is Highridge's acquisition of spine assets from Accelus, underscoring the survival pressures on undercapitalized players.
To clarify, Accelus is gone. All employees were RIFed (except 2 that were absorbed by Highridge), email is shut down, legal entity is closed.
Accelus, a growth-stage spine device company specializing in expandable spinal implants, ran into financial challenges and sold its core assets—including the FlareHawk/Toro interbody fusion systems, LineSider pedicle screws, inventory, and intellectual property—to Highridge Medical at a discounted price (undisclosed).
Inside this article
Analysis of Highridge Medical's strategic asset sale of Accelus, offering insights into the evolving spine surgery market, industry consolidation trends, and how ...
